National Cmv Foundation is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G128). Contributions are tax-deductible.
1646 W Snow Ave Suite 84, Tampa, FL 33606-2837
Among the 11 scored disease & disorders organizations in Tampa, National Cmv Foundation holds 6.9 months of operating reserves (peer median 15.6 months), runs a typical yearly deficit of 29.7% (peers: deficit of 12.7%), and has grown spending 3.5% a year (peers: grown spending 8.5% a year).
In fiscal year 2024 it reported $346,360 in revenue and $492,551 in expenses, with contributions making up 98.8% of revenue.
Our mission is to prevent pregnancy loss, childhood death, and disability due to congenital CMV. Our strategic goals are to: raise awareness through advocacy accelerate mission-driven research target education programs grow resources in support of the mission demonstrate commitment to diversity, equity and inclusion
Largest programs · fiscal year 2024
Public Health Awareness: The National CMV Foundation creates and disseminates evidence-based health education on congenital CMV, including prevention strategies during pregnancy, modes of transmission, potential outcomes, newborn screening, treatment options, and relevant public health policies. Through diverse communication channels, such as web content, email marketing, social media, paid media,… Read more
Public Health Awareness: The National CMV Foundation creates and disseminates evidence-based health education on congenital CMV, including prevention strategies during pregnancy, modes of transmission, potential outcomes, newborn screening, treatment options, and relevant public health policies. Through diverse communication channels, such as web content, email marketing, social media, paid media, print materials, videos, toolkits, educational downloads, and continuing education activities, the Foundation reaches women of childbearing age, families, child care providers, and healthcare professionals nationwide.In 2024, the Foundations advocacy leadership contributed to the introduction of the Stop CMV Act, the first federally coordinated effort aiming to provide funding and incentives to increase screening of newborns for congenital cytomegalovirus.
$166,078 spent · 62.5% of program spending
Community Building: Representatives of the National CMV Foundation hosted a variety of in-person and virtual events designed to strengthen community engagement, raise awareness, and expand advocacy for congenital CMV risk reduction. These gatherings included educational webinars, advocacy trainings, and fundraising events that united families, healthcare professionals, and partners nationwide, bui… Read more
Community Building: Representatives of the National CMV Foundation hosted a variety of in-person and virtual events designed to strengthen community engagement, raise awareness, and expand advocacy for congenital CMV risk reduction. These gatherings included educational webinars, advocacy trainings, and fundraising events that united families, healthcare professionals, and partners nationwide, building connection, empowerment, and sustained support for those impacted by CMV.
$99,547 spent · 37.5% of program spending
RESEARCH SUPPORT: The National CMV Foundation supports a range of research initiatives and efforts, including workshops and grants for young investigators and early-career researchers studying maternal or congenital CMV infection. Areas of focus include public health, epidemiology, diagnosis, treatment, outcomes, basic science, and vaccine development, all aligned with the Foundations mission to p… Read more
RESEARCH SUPPORT: The National CMV Foundation supports a range of research initiatives and efforts, including workshops and grants for young investigators and early-career researchers studying maternal or congenital CMV infection. Areas of focus include public health, epidemiology, diagnosis, treatment, outcomes, basic science, and vaccine development, all aligned with the Foundations mission to promote maternal and newborn health and reduce the incidence of congenital CMV in the United States. Representatives of the National CMV Foundation were also instrumental in securing the FY '24 inclusion of congenital CMV in the Department of Defenses Peer-Reviewed Medical Research Program, opening new opportunities for federally funded CMV research and innovation, totaling over $700,000.
Where each dollar went · fiscal year 2024
Of every dollar it spent, 54¢ went to programs, 35¢ to management and 11¢ to fundraising.
Programs $265,625
Management $173,979
Fundraising $52,947
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
54%
Below
Compared with Tampa peers
Measure
This organization
Peer median
Operating reserves
6.9 mo
15.6 mo
Typical margin
−29.7%
−12.7%
Spending growth
+3.5% / yr
+8.5% / yr
Debt load
4.3%
4.3%
Peers: the 11 Tampa disease & disorders organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$346,360Fiscal year 2024
Expenses$492,551Fiscal year 2024
Total assets$295,527Fiscal year 2024
Total liabilities$12,821Fiscal year 2024
Fiscal year ending December2024
Revenue$346,360
Expenses$492,551
Net income−$146,191
Net assets$282,706
Notable sources of revenue
Percent of total revenue
Contributions
$342,370
98.8%
Program services
$0
0.0%
Investment income
$3,990
1.2%
Other (net)
$0
0.0%
Assets / debt
Total assets
$295,527
Total liabilities
$12,821
Net assets
$282,706
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$382,031
Expenses$455,965
Net income−$73,934
Net assets$419,643
Notable sources of revenue
Percent of total revenue
Contributions
$378,729
99.1%
Program services
$0
0.0%
Investment income
$3,302
0.9%
Other (net)
$0
0.0%
Assets / debt
Total assets
$424,637
Total liabilities
$4,994
Net assets
$419,643
Compensation
Officers and key employees
$0
Share of expenses
0.0%
Fiscal year ending December2022
Revenue$280,538
Expenses$459,678
Net income−$179,140
Net assets$450,005
Notable sources of revenue
Percent of total revenue
Contributions
$277,975
99.1%
Program services
$0
0.0%
Investment income
$2,455
0.9%
Other (net)
$108
0.0%
Assets / debt
Total assets
$455,934
Total liabilities
$5,929
Net assets
$450,005
Compensation
Officers and key employees
$0
Share of expenses
0.0%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?